These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Discovery and evaluation of 3,5-disubstituted indole derivatives as Pim kinase inhibitors. More KN; Hong VS; Lee A; Park J; Kim S; Lee J Bioorg Med Chem Lett; 2018 Aug; 28(14):2513-2517. PubMed ID: 29871845 [TBL] [Abstract][Full Text] [Related]
12. Pim kinase inhibitory and antiproliferative activity of a novel series of meridianin C derivatives. More KN; Jang HW; Hong VS; Lee J Bioorg Med Chem Lett; 2014 Jun; 24(11):2424-8. PubMed ID: 24775304 [TBL] [Abstract][Full Text] [Related]
13. New Approaches for the Uses of Cyclohexan-1,4-dione for the Synthesis of 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-b]pyridine Derivatives used as Potential Anti-prostate Cancer Agents and Pim-1 Kinase Inhibitors. Mohareb RM; Abdo NYM; El-Sharkawy KA Anticancer Agents Med Chem; 2018; 18(12):1736-1749. PubMed ID: 29866019 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of quinoline derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors. Li K; Li Y; Zhou D; Fan Y; Guo H; Ma T; Wen J; Liu D; Zhao L Bioorg Med Chem; 2016 Apr; 24(8):1889-97. PubMed ID: 26979485 [TBL] [Abstract][Full Text] [Related]
16. Discovery of novel triazolo[4,3-b]pyridazin-3-yl-quinoline derivatives as PIM inhibitors. Martínez-González S; Rodríguez-Arístegui S; Gómez de la Oliva CA; Hernández AI; González Cantalapiedra E; Varela C; García AB; Rabal O; Oyarzabal J; Bischoff JR; Klett J; Albarrán MI; Cebriá A; Ajenjo N; García-Serelde B; Gómez-Casero E; Cuadrado-Urbano M; Cebrián D; Blanco-Aparicio C; Pastor J Eur J Med Chem; 2019 Apr; 168():87-109. PubMed ID: 30802730 [TBL] [Abstract][Full Text] [Related]
17. Mechanistic selectivity investigation and 2D-QSAR study of some new antiproliferative pyrazoles and pyrazolopyridines as potential CDK2 inhibitors. Hassan GS; Georgey HH; Mohammed EZ; George RF; Mahmoud WR; Omar FA Eur J Med Chem; 2021 Jun; 218():113389. PubMed ID: 33784602 [TBL] [Abstract][Full Text] [Related]
18. New potent and selective inhibitor of Pim-1/3 protein kinases sensitizes human colon carcinoma cells to doxorubicin. Moreau P; Dezhenkova LG; Anizon F; Nauton L; Thery V; Liang S; Kaluzhny DN; Shtil AA Anticancer Agents Med Chem; 2014; 14(9):1228-36. PubMed ID: 25175798 [TBL] [Abstract][Full Text] [Related]
19. Synthesis of Tetrahydrobenzo[ Mohareb RM; Wardakhan WW; Abbas NS Anticancer Agents Med Chem; 2019; 19(14):1737-1753. PubMed ID: 30947678 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and docking study of pyridine and thieno[2,3-b] pyridine derivatives as anticancer PIM-1 kinase inhibitors. Abdelaziz ME; El-Miligy MMM; Fahmy SM; Mahran MA; Hazzaa AA Bioorg Chem; 2018 Oct; 80():674-692. PubMed ID: 30064079 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]